By integrating in situ proximity ligation assays (isPLA; Navinci Diagnostics) to map the PD‐1/PD‐L1 interaction landscape, they identified macrophage–tumour cell barriers linked to immunotherapy resistance, as well as B‐ and T‐cell aggregates near tumour boundaries in responders.180. Here, PDCD1 is linked to neoplasm.